Recombinant erythropoietin biosimilar (Lupin)

重组人促红素生物类似药（Lupin）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant erythropoietin biosimilar (Lupin)
Drug Alias Name重组人促红素生物仿制药（Lupin）rHuEPO biosimilarErythropoietin biosimilarEpocept
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionErythropoiesis stimulantsErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsAnemia
Global Approved IndicationsAnemia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2011/01/01
Country/TerritoryIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLupin Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLupin Ltd
Inactive CompaniesN/A
Active IndicationsAnemia
Inactive IndicationsN/A

Other Information

ATC CodeB03XA01
Related LinksN/A